- About CURE
Timothy Donahue, MD
Assistant Professor, Department of Surgery, David Geffen School of Medicine at UCLA
Dr. Timothy R. Donahue (MD) is an Assistant Professor of Surgery, Division of General Surgery, Core Member of the UCLA Center for Pancreatic Diseases, with a dual appointment in the Department of Molecular and Medical Pharmacology. Dr. Donahue was recruited to UCLA to develop a translational research program within the UCLA Center for Pancreatic Diseases to compliment its clinical prominence. This program has become the UCLA Pancreatic Cancer Clinical / Translational Research Program within the Jonsson Comprehensive Cancer Center (JCCC) and Institute for Molecular Medicine (IMED). Dr. Donahue has successfully bridged his pancreatic surgery practice with his pancreatic cancer research program. He is a pancreatic surgeon and has quickly built a refined clinical practice that is focused on patients with pancreatic cancer. . Over the past 2 years, he has 1) created and maintained the comprehensive pancreatic cancer database; 2) participated in an imaging trial examining a novel PET probe to measure deoxycytidine kinase activity in patients with pancreatic cancer; 3) organized a multidisciplinary team to complete an integrative survival-based array analysis of human pancreatic cancer (manuscript under review at Clinical Cancer Research on which he is the first author); 4) initiated the human tumor xenograft model, and 5) secured a number of early career grants to examine the role of miRNA regulation of PI3K/AKT and SRC signaling and the impact of the tumor associated stroma on tumorigenesis and gemcitabine resistance in human pancreatic cancer.